Maha Katabi - 17 Nov 2023 Form 4 Insider Report for RayzeBio, Inc.

Role
Director
Signature
/s/ Jeff Woodley, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Nov 2023
Net transactions value
$0
Form type
4
Filing time
17 Nov 2023, 18:37:06 UTC
Previous filing
21 Sep 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYZB Stock Option (right to buy) Award $0 +18,235 $0.000000 18,235 17 Nov 2023 Common Stock 18,235 $22.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board through such vesting date.